Prime Biosciences is a European distributor of high-end medical products and diagnostics, with a mission to enhance the quality of life worldwide. The company leverages its deep understanding of local markets to steadily expand, meeting the expectations of partners while upholding core principles of Trust, Quality, and Innovation.
Specializing in comprehensive and innovative offerings for disease prevention, diagnosis, and treatment, Prime Biosciences is dedicated to addressing unmet needs in multiple markets. As a spin-off from a major Greek pharmaceutical and medical devices firm, the company is led by seasoned professionals with extensive sales and marketing expertise in the healthcare sectors of Europe and the US.
Founded in 2018, the company's goal is to narrow the gap between medical progression and patients' requirements. By forming strategic partnerships, Prime Biosciences represents and distributes top-tier products and medical equipment, tailoring solutions to specific contexts. The focus remains on delivering optimal responses to individual patient and healthcare provider needs, while also strengthening the market presence of partners.
With a focus on Health Care and Pharmaceutical industries, Prime Biosciences is headquartered in Greece, signaling potential growth and impact in the European market.
There is no investment information
No recent news or press coverage available for Prime Biosciences.